Home > Products > INOMAX (NITRIC OXIDE) FOR INHALATION

INOMAX (NITRIC OXIDE) FOR INHALATION

Company : IKARIA Inc

UMDC Code : 452052

INOMAX is approved by the FDA to treat term and near-term (greater than 34 weeks) infants with HRF associated with pulmonary hypertension. INOMAX is an inhaled drug that helps to relax or open up the blood vessels of the lungs in newborns. This, in turn, helps the infants heart and lungs process more oxygen and deliver more oxygenated blood to the rest of the body.2. Nitric oxide (NO) is able to penetrate cell membranes to deliver a signal to nearby muscles to relax.3 As the muscles relax, blood flow increases, helping the heart and lungs to process more oxygen and deliver more oxygenated blood to a babys body. The researchers who discovered the role of NO in the human body earned the Nobel Prize for Physiology or Medicine.3,4

Product URL : http://www.ikaria.com/patients/inomax.html

Last Updated : 03/16/2013

Please provide the following information and a representative of IKARIA Inc will contact you to assist with any questions you might have.